Cannabidiol and Marihuana Research Expansion Act
USA116th CongressS-2032| Senate
| Updated: 12/16/2020
Dianne Feinstein
Democratic Senator
California
Cosponsors (11)
Judiciary Committee, United States Senate Caucus on International Narcotics Control
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Cannabidiol and Marihuana Research Expansion Act This bill modifies provisions concerning the federal regulation of certain drugs that are deemed to pose a risk of abuse and dependence to facilitate research on, and the use of, medical treatments containing marijuana and its derivatives.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S4633-4634)
Committee on United States Senate Caucus on International Narcotics Control. Hearings held. Hearings printed: S.Hrg. 116-252.
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7504-7507)
Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7504-7507)
Senate Committee on the Judiciary discharged by Unanimous Consent.
Measure laid before Senate by unanimous consent. (consideration: CR S7508)
Message on Senate action sent to the House.
Received in the House.
Held at the desk.
Crime and Law Enforcement
Congressional oversightDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesHealth personnelHealth programs administration and fundingLicensing and registrationsMedical researchPublic-private cooperationResearch administration and fundingTrade restrictions
Cannabidiol and Marihuana Research Expansion Act
USA116th CongressS-2032| Senate
| Updated: 12/16/2020
Cannabidiol and Marihuana Research Expansion Act This bill modifies provisions concerning the federal regulation of certain drugs that are deemed to pose a risk of abuse and dependence to facilitate research on, and the use of, medical treatments containing marijuana and its derivatives.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S4633-4634)
Committee on United States Senate Caucus on International Narcotics Control. Hearings held. Hearings printed: S.Hrg. 116-252.
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7504-7507)
Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7504-7507)
Senate Committee on the Judiciary discharged by Unanimous Consent.
Measure laid before Senate by unanimous consent. (consideration: CR S7508)
Message on Senate action sent to the House.
Received in the House.
Held at the desk.
Dianne Feinstein
Democratic Senator
California
Cosponsors (11)
Judiciary Committee, United States Senate Caucus on International Narcotics Control
Crime and Law Enforcement
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Congressional oversightDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesHealth personnelHealth programs administration and fundingLicensing and registrationsMedical researchPublic-private cooperationResearch administration and fundingTrade restrictions